Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Iparomlimab/Tuvonralimab Plus SBRT and Lenvatinib for Perioperative Treatment of Potentially Resectable Intermediate-Stage HCC

Tianjin Medical University Cancer Institute and Hospital · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
hepatocellular-carcinoma
hcc - hepatocellular carcinoma, hepatocellular carcinoma, iparomlimab/tuvonralimab, stereotactic body radiation therapy, lenvatinib, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 876138
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.